Cortical Bone Derived Stem Cells for Cardiac Wound Healing

Korean Circulation Journal
Sadia Mohsin, Steven R Houser

Abstract

Ischemic heart disease can lead to myocardial infarction (MI), a major cause of morbidity and mortality worldwide. Adoptive transfer of multiple stem cell types into failing human hearts has demonstrated safety however the beneficial effects in patients with cardiovascular disorders have been modest. Modest improvement in patients with cardiac complications warrants identification of a novel stem cell population that possesses effective reparative properties and improves cardiac function after injury. Recently we have shown in a mouse model and a porcine pre-clinical animal model, that cortical bone derived stem cells (CBSCs) enhance cardiac function after MI and/or ischemia-reperfusion injury. These beneficial effects of allogeneic cell delivery appear to be mediated by paracrine mechanisms rather than by transdifferentiation of injected cells into vessels and/or immature myocytes. This review will discuss role of CBSCs in cardiac wound healing. After having modest beneficial improvement in most of the clinical trials, a critical need is to understand the interaction of the transplanted stem cells with the ischemic cardiac environment. Transplanted stem cells are exposed to pro-inflammatory factors and activated immune cells a...Continue Reading

References

Jul 25, 2000·Circulation·B H Lorell, B A Carabello
Apr 5, 2001·Nature·D OrlicP Anversa
Jan 30, 2003·Journal of Cardiac Failure·A Martin Gerdes
Feb 26, 2003·Circulation Research·Valentino PiacentinoSteven R Houser
Sep 25, 2003·Cell·Antonio P BeltramiPiero Anversa
Nov 13, 2003·Physiological Genomics·Andy Wessels, David Sedmera
Jul 12, 2005·Annual Review of Biomedical Engineering·Jeffrey W HolmesJames W Covell
Mar 22, 2006·Circulation·Piero AnversaRoberto Bolli
Apr 4, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Massimiliano GnecchiVictor J Dzau
Apr 19, 2006·Journal of Cellular Biochemistry·Arnold I Caplan, James E Dennis
Jun 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Konrad UrbanekAnnarosa Leri
Sep 23, 2006·The New England Journal of Medicine·Volker SchächingerUNKNOWN REPAIR-AMI Investigators
Jan 19, 2007·Nature Clinical Practice. Cardiovascular Medicine·Ramesh Mazhari, Joshua M Hare
Oct 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Marcello RotaPiero Anversa
Nov 26, 2008·Circulation Research·Massimiliano GnecchiVictor J Dzau
Nov 2, 2012·Fibrogenesis & Tissue Repair·Michael P Czubryt
Jan 29, 2013·Current Heart Failure Reports·John H LoughranRoberto Bolli
May 30, 2013·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Panagiota ChristiaNikolaos G Frangogiannis
Feb 27, 2014·The Journal of Clinical Investigation·Arin B AuroraEric N Olson
May 9, 2014·Nature·Jop H van BerloJeffery D Molkentin
Oct 29, 2014·Proceedings of the National Academy of Sciences of the United States of America·Kory J LavineDouglas L Mann
Jan 24, 2015·Nature Reviews. Immunology·Slava EpelmanDouglas L Mann
Apr 11, 2015·Circulation Research·Vasileios Karantalis, Joshua M Hare

❮ Previous
Next ❯

Citations

Apr 25, 2020·Frontiers in Immunology·Marcus J WagnerSadia Mohsin
Oct 9, 2021·American Journal of Physiology. Heart and Circulatory Physiology·Giana J SchenaSteven R Houser

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.